AceMap AI
AceMapAI provides AI-powered platforms that speed up the discovery of new drugs. The company uses AI to analyze genes, predict target functionality, and assess molecule druggability. It operates as B2B SaaS platforms and has established three high-performing AI drug discovery platforms to support collaborations and licensing. The team combines expertise from medicine, synthetic biology, chemical engineering, computational chemistry, and biology. The platform is used in early drug discovery to shorten discovery time and reduce costs, serving researchers and pharmaceutical partners.
AceMap AI
AceMapAI provides AI-powered platforms that speed up the discovery of new drugs. The company uses AI to analyze genes, predict target functionality, and assess molecule druggability. It operates as B2B SaaS platforms and has established three high-performing AI drug discovery platforms to support collaborations and licensing. The team combines expertise from medicine, synthetic biology, chemical engineering, computational chemistry, and biology. The platform is used in early drug discovery to shorten discovery time and reduce costs, serving researchers and pharmaceutical partners.